{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:49:08Z","timestamp":1776379748340,"version":"3.51.2"},"reference-count":195,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.prp.2022.154053","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:47:40Z","timestamp":1659142060000},"page":"154053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay"],"prefix":"10.1016","volume":"237","author":[{"given":"Ahmed S.","family":"Doghish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"Elrebehy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah M.M.","family":"Elbadry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hend H.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma M.","family":"Farouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada A. Abu","family":"Serea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahma Ali A.","family":"Elghany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kholoud K.","family":"El-Halwany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman Omar","family":"Alsawah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hla I.","family":"Dewidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham A.","family":"El-Mahdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10299","key":"10.1016\/j.prp.2022.154053_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2013.284692","article-title":"Smoking prevalence and cigarette consumption in 187 countries, 1980-2012","volume":"311","author":"Ng","year":"2014","journal-title":"JAMA"},{"issue":"68","key":"10.1016\/j.prp.2022.154053_bib3","first-page":"7","volume":"2018","author":"Siegel","year":"2018","journal-title":"Cancer Stat."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib4","first-page":"5","article-title":"Overexpression of microRNA\u2011124\u20135p sensitizes non\u2011small cell lung cancer cells to treatment with 5\u2013fluorouracil via AEG\u20111 regulation","volume":"21","author":"Tan","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2022.154053_bib5","article-title":"Frontiers of MicroRNA signature in non-small cell","volume":"9","author":"Zhu","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prp.2022.154053_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00267","article-title":"Drug resistance in non-small cell lung cancer: a potential for NOTCH targeting?","volume":"8","author":"Sosa Iglesias","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2022.154053_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mgene.2018.11.006","article-title":"Diagnostic significance of miR-639 and miR-10b in \u03b2reast cancer patients","volume":"19","author":"Ismail","year":"2019","journal-title":"Meta Gene"},{"issue":"3","key":"10.1016\/j.prp.2022.154053_bib8","first-page":"143","article-title":"MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics","volume":"4","author":"Iorio","year":"2012","journal-title":"A Compr. Rev."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv303","article-title":"PDL1 Regulation by p53 via miR-34","volume":"108","author":"Cortez","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2022.154053_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijbiomac.2021.12.141","article-title":"A review of the biological role of miRNAs in prostate cancer suppression and progression","volume":"197","author":"Doghish","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2022.154053_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118518","article-title":"El-Din, Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein","volume":"262","author":"El-Mahdy","year":"2020","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.prp.2022.154053_bib12","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/cells8080840","article-title":"Role of miRNA-regulated cancer stem cells in the pathogenesis of human malignancies","volume":"8","author":"Khan","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40064-016-3425-5","article-title":"Regulatory mechanisms of microRNAs in lung cancer stem cells","volume":"5","author":"Fan","year":"2016","journal-title":"Springerplus"},{"issue":"5","key":"10.1016\/j.prp.2022.154053_bib14","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.18632\/oncotarget.13933","article-title":"miR-494\u20133p is a novel tumor driver of lung carcinogenesis","volume":"8","author":"Faversani","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2022.154053_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jnutbio.2017.02.020","article-title":"miR-19 targeting of GSK3\u03b2 mediates sulforaphane suppression of lung cancer stem cells","volume":"44","author":"Zhu","year":"2017","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib16","first-page":"1","article-title":"Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2022.154053_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.omto.2020.09.005","article-title":"microRNA-130b-3p contained in MSC-derived EVs promotes lung cancer progression by regulating the FOXO3\/NFE2L2\/TXNRD1 axis","volume":"20","author":"Guo","year":"2021","journal-title":"Mol. Ther. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib18","first-page":"96","article-title":"MiR-133a and MiR-155 as potential minimally invasive biomarkers in breast cancer","volume":"7","author":"Elshimy","year":"2017","journal-title":"Cancer Biol."},{"issue":"6","key":"10.1016\/j.prp.2022.154053_bib19","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.3892\/ijo.2016.3465","article-title":"MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2","volume":"48","author":"Zhang","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.prp.2022.154053_bib20","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1158\/1078-0432.CCR-16-1025","article-title":"Combining anti-miR-155 with chemotherapy for the treatment of lung cancers","volume":"23","author":"Van Roosbroeck","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"51","key":"10.1016\/j.prp.2022.154053_bib21","doi-asserted-by":"crossref","first-page":"84508","DOI":"10.18632\/oncotarget.13022","article-title":"MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN","volume":"7","author":"Xue","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.prp.2022.154053_bib22","first-page":"1172","article-title":"MiR-101 inhibits the proliferation and metastasis of lung cancer by targeting zinc finger E-box binding homeobox 1","volume":"10","author":"Han","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"4","key":"10.1016\/j.prp.2022.154053_bib23","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.sjbs.2021.02.001","article-title":"MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8","volume":"28","author":"Elkady","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.prp.2022.154053_bib24","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1177\/0300060519856505","article-title":"miR-16 regulates proliferation and invasion of lung cancer cells via the ERK\/MAPK signaling pathway by targeted inhibition of MAPK kinase 1 (MEK1)","volume":"47","author":"Chen","year":"2019","journal-title":"J. Int. Med. Res."},{"issue":"5","key":"10.1016\/j.prp.2022.154053_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3727\/096504016X14685034103194","article-title":"MicroRNA-16-1 inhibits tumor cell proliferation and induces apoptosis in A549 non-small cell lung carcinoma cells","volume":"24","author":"Wang","year":"2016","journal-title":"Oncol. Res."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib26","first-page":"53","article-title":"MiR-338-3p inhibits the growth and invasion of non-small cell lung cancer cells by targeting IRS2","volume":"7","author":"Zhang","year":"2017","journal-title":"Am. J. Cancer Res"},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib27","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3892\/mmr.2014.2880","article-title":"microRNA-338-3p functions as a tumor suppressor in human non\u2011small\u2011cell lung carcinoma and targets Ras-related protein 14","volume":"11","author":"Sun","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"23","key":"10.1016\/j.prp.2022.154053_bib28","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1038\/onc.2010.642","article-title":"MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14)","volume":"30","author":"Wang","year":"2011","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib29","first-page":"1155","article-title":"MicroRNA\u2011433 reduces cell proliferation and invasion in non\u2011small cell lung cancer via directly targeting E2F transcription factor 3","volume":"18","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.prp.2022.154053_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317706215","article-title":"MicroRNA-124 suppresses proliferation and glycolysis in non\u2013small cell lung cancer cells by targeting AKT\u2013GLUT1\/HKII","volume":"39","author":"Zhao","year":"2017","journal-title":"Tumor Biol."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/14756366.2021.2015343","article-title":"New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies","volume":"37","author":"Elkady","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/14756366.2021.2015342","article-title":"1, 3, 4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies","volume":"37","author":"Hagras","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"46","key":"10.1016\/j.prp.2022.154053_bib33","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1039\/D1RA04345E","article-title":"Rouby, Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer","volume":"11","author":"Doghish","year":"2021","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib34","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/14756366.2021.1901089","article-title":"Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"36","author":"Kassab","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.prp.2022.154053_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/117693510700300026","article-title":"Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays","volume":"3","author":"Tsiambas","year":"2007","journal-title":"Cancer Inform."},{"issue":"5","key":"10.1016\/j.prp.2022.154053_bib36","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.5114\/aoms.2020.97967","article-title":"Differential expression of angiogenesis-related miRNAs and VEGFA in cirrhosis and hepatocellular carcinoma","volume":"16","author":"de Oliveira","year":"2020","journal-title":"Arch. Med Sci."},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib37","first-page":"657","article-title":"AngiomiRs: MicroRNAs driving angiogenesis in cancer","volume":"43","author":"Salinas\u2011Vera","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.prp.2022.154053_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153886","article-title":"miRNAs inspirations in hepatocellular carcinoma: detrimental and favorable aspects of key performers","author":"El-Mahdy","year":"2022","journal-title":"Pathol. -Res. Pract."},{"issue":"6","key":"10.1016\/j.prp.2022.154053_bib39","first-page":"4935","article-title":"MicroRNA\u2011214 upregulates HIF\u20111\u03b1 and VEGF by targeting ING4 in lung cancer cells","volume":"19","author":"Li","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.prp.2022.154053_bib40","first-page":"3525","article-title":"miR-486-5p inhibits cell proliferation and invasion through repressing GAB2 in non-small cell lung cancer","volume":"16","author":"Yu","year":"2018","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.prp.2022.154053_bib41","first-page":"6312","article-title":"MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1\/MAPK pathway","volume":"8","author":"Zhou","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"11","key":"10.1016\/j.prp.2022.154053_bib42","first-page":"2519","article-title":"miR-873 induces lung adenocarcinoma cell proliferation and migration by targeting SRCIN1","volume":"7","author":"Gao","year":"2015","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11010-013-1795-3","article-title":"MiR-199a suppresses the hypoxia-induced proliferation of non-small cell lung cancer cells through targeting HIF1\u03b1","volume":"384","author":"Ding","year":"2013","journal-title":"Mol. Cell. Biochem."},{"issue":"13","key":"10.1016\/j.prp.2022.154053_bib44","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/j.ejca.2014.06.005","article-title":"microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C","volume":"50","author":"Hu","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib45","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3892\/mmr.2014.2880","article-title":"microRNA-338-3p functions as a tumor suppressor in human non\u2011small\u2011cell lung carcinoma and targets Ras-related protein 14","volume":"11","author":"Sun","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.prp.2022.154053_bib46","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3390\/ijms20071611","article-title":"The roles of MicroRNA in lung cancer","volume":"20","author":"Wu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.prp.2022.154053_bib47","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/2211-5463.12738","article-title":"MicroRNA\u20107\u20135p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non\u2010small cell lung cancer","volume":"9","author":"Li","year":"2019","journal-title":"FEBS Open bio"},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib48","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1080\/14756366.2022.2086866","article-title":"Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo [3, 4-d] pyrimidine and pyrazolo [4, 3-e][1, 2, 4] triazolo [1, 5-c] pyrimidine scaffold with apoptotic activity","volume":"37","author":"Mandour","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"8","key":"10.1016\/j.prp.2022.154053_bib49","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1111\/jcmm.14404","article-title":"MiR\u201034b\u20103p represses cell proliferation, cell cycle progression and cell apoptosis in non\u2010small\u2010cell lung cancer (NSCLC) by targeting CDK4","volume":"23","author":"Feng","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12935-017-0415-9","article-title":"MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2","volume":"17","author":"Zhang","year":"2017","journal-title":"Cancer Cell Int."},{"issue":"20","key":"10.1016\/j.prp.2022.154053_bib51","first-page":"6845","article-title":"MiR-24 promotes the proliferation and apoptosis of lung carcinoma via targeting MAPK7","volume":"22","author":"Zhou","year":"2018","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"3","key":"10.1016\/j.prp.2022.154053_bib52","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1159\/000488831","article-title":"Effect of miR-21 on apoptosis in lung cancer cell through inhibiting the PI3K\/Akt\/NF-\u03baB signaling pathway in vitro and in vivo","volume":"46","author":"Zhou","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/00368504211009379","article-title":"MiR-326 mediates malignant biological behaviors of lung adenocarcinoma by targeting ZEB1","volume":"104","author":"Liu","year":"2021","journal-title":"Sci. Prog."},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/cancers11020265","article-title":"MicroRNA in lung cancer metastasis","volume":"11","author":"Wu","year":"2019","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib55","doi-asserted-by":"crossref","first-page":"331","DOI":"10.7150\/jca.18188","article-title":"MiR-378 and MiR-1827 regulate tumor invasion, migration and angiogenesis in human lung adenocarcinoma by targeting RBX1 and CRKL, respectively","volume":"9","author":"San","year":"2018","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib56","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/21655979.2021.1886771","article-title":"Tumor-derived exosomal miRNA-141 promote angiogenesis and malignant progression of lung cancer by targeting growth arrest-specific homeobox gene (GAX)","volume":"12","author":"Wang","year":"2021","journal-title":"Bioengineered"},{"issue":"8","key":"10.1016\/j.prp.2022.154053_bib57","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1073\/pnas.1917531117","article-title":"miR-196b-5p\u2013mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer","volume":"117","author":"Liang","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prp.2022.154053_bib58","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.canlet.2017.06.002","article-title":"Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C","volume":"402","author":"Chang","year":"2017","journal-title":"Cancer Lett."},{"issue":"18","key":"10.1016\/j.prp.2022.154053_bib59","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1038\/onc.2016.414","article-title":"Downregulation of miR-218 contributes to epithelial\u2013mesenchymal transition and tumor metastasis in lung cancer by targeting Slug\/ZEB2 signaling","volume":"36","author":"Shi","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-07561-8","article-title":"miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC","volume":"9","author":"Jeon","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib61","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ymthe.2017.11.016","article-title":"Hypoxic lung-cancer-derived extracellular vesicle microRNA-103a increases the oncogenic effects of macrophages by targeting PTEN","volume":"26","author":"Hsu","year":"2018","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.prp.2022.154053_bib62","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/ijc.31988","article-title":"Circulating mir\u2010320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk","volume":"144","author":"Fortunato","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2022.154053_bib63","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/carcin\/bgab023","article-title":"microRNA-320b suppresses HNF4G and IGF2BP2 expression to inhibit angiogenesis and tumor growth of lung cancer","volume":"42","author":"Ma","year":"2021","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib64","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11010-020-03936-y","article-title":"MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K\/Akt signaling pathway","volume":"476","author":"Han","year":"2021","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2021.12222","article-title":"Regulation of angiogenesis by microRNAs in cancer","volume":"24","author":"Zheng","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"12","key":"10.1016\/j.prp.2022.154053_bib66","doi-asserted-by":"crossref","first-page":"23596","DOI":"10.1002\/jcp.28928","article-title":"miR\u2010942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non\u2010small\u2010cell lung cancer","volume":"234","author":"Yang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2022.154053_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108656","article-title":"Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase","volume":"160","author":"Ismail","year":"2020","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib68","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12931-019-0994-1","article-title":"Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data","volume":"20","author":"Chen","year":"2019","journal-title":"Respir. Res"},{"issue":"5","key":"10.1016\/j.prp.2022.154053_bib69","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317706215","article-title":"MicroRNA-124 suppresses proliferation and glycolysis in non\u2013small cell lung cancer cells by targeting AKT\u2013GLUT1\/HKII","volume":"39","author":"Zhao","year":"2017","journal-title":"Tumor Biol."},{"issue":"4","key":"10.1016\/j.prp.2022.154053_bib70","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.1002\/jcb.27961","article-title":"Downregulation of miR\u201033b promotes non\u2010small cell lung cancer cell growth through reprogramming glucose metabolism miR\u201033b regulates non\u2010small cell lung cancer cell growth","volume":"120","author":"Zhai","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.prp.2022.154053_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112735","article-title":"The regulatory role of autophagy-related miRNAs in lung cancer drug resistance","volume":"148","author":"Shahverdi","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.prp.2022.154053_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-2031-1","article-title":"MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3\u2019UTR and predicts poor survival in non-small cell lung cancer","volume":"10","author":"Duan","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib73","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3892\/mmr.2016.5332","article-title":"MicroRNA-27b reverses docetaxel resistance of non-small cell lung carcinoma cells via targeting epithelial growth factor receptor","volume":"14","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.prp.2022.154053_bib74","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3892\/ol.2014.2500","article-title":"MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel","volume":"8","author":"Liu","year":"2014","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1746-1596-9-143","article-title":"MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4","volume":"9","author":"Ning","year":"2014","journal-title":"Diagn. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2022.154053_bib76","first-page":"384","article-title":"[MiR-192 confers cisplatin resistance by targeting Bim in lung cancer]","volume":"17","author":"Zhang","year":"2014","journal-title":"Zhongguo Fei Ai Za Zhi Chin. J. Lung Cancer"},{"issue":"4","key":"10.1016\/j.prp.2022.154053_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094639","article-title":"miRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC","volume":"9","author":"Jiang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib78","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2020.12266","article-title":"Overexpression of microRNA\u2011124\u20135p sensitizes non\u2011small cell lung cancer cells to treatment with 5\u2013fluorouracil via AEG\u20111 regulation","volume":"21","author":"Tan","year":"2021","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.prp.2022.154053_bib79","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.3892\/or.2013.2755","article-title":"miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN","volume":"30","author":"Lei","year":"2013","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib80","doi-asserted-by":"crossref","first-page":"15870","DOI":"10.1038\/ncomms15870","article-title":"Simultaneous overactivation of Wnt\/\u03b2-catenin and TGF\u03b2 signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC","volume":"8","author":"Cai","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2022.154053_bib81","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.biopha.2016.09.027","article-title":"miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1","volume":"84","author":"Su","year":"2016","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2022.154053_bib82","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.biopha.2018.07.024","article-title":"miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1","volume":"106","author":"Deng","year":"2018","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.prp.2022.154053_bib83","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/cbin.10995","article-title":"MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy","volume":"42","author":"Hua","year":"2018","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.prp.2022.154053_bib84","article-title":"mir-126-5p promotes cisplatin sensitivity of non-small-cell lung cancer by inhibiting ADAM9","volume":"2021","author":"Liu","year":"2021","journal-title":"Biomed. Res Int."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib85","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4149\/neo_2019_190511N420","article-title":"miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs)","volume":"67","author":"Liu","year":"2020","journal-title":"Neoplasma"},{"key":"10.1016\/j.prp.2022.154053_bib86","doi-asserted-by":"crossref","first-page":"31651","DOI":"10.1038\/srep31651","article-title":"Up- regulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy","volume":"6","author":"Ma","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.prp.2022.154053_bib87","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3892\/or.2017.5448","article-title":"miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM","volume":"37","author":"Guo","year":"2017","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib88","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3892\/mmr.2016.5394","article-title":"Inhibition of microRNA-155 sensitizes lung cancer cells to irradiation via suppression of HK2-modulated glucose metabolism","volume":"14","author":"Lv","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.prp.2022.154053_bib89","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.3892\/mmr.2016.5010","article-title":"MicroRNA-21 modulates radiation resistance through upregulation of hypoxia-inducible factor-1\u03b1-promoted glycolysis in non-small cell lung cancer cells","volume":"13","author":"Jiang","year":"2016","journal-title":"Mol. Med Rep."},{"issue":"3","key":"10.1016\/j.prp.2022.154053_bib90","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317695010","article-title":"Tumor suppressor miR-29c regulates radioresistance in lung cancer cells","volume":"39","author":"Arechaga-Ocampo","year":"2017","journal-title":"Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med."},{"issue":"9","key":"10.1016\/j.prp.2022.154053_bib91","doi-asserted-by":"crossref","first-page":"11927","DOI":"10.1007\/s13277-016-5052-8","article-title":"Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer","volume":"37","author":"Chen","year":"2016","journal-title":"Tumor Biol."},{"issue":"4","key":"10.1016\/j.prp.2022.154053_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196350","article-title":"Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients","volume":"13","author":"Bisagni","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2022.154053_bib93","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.lungcan.2017.02.020","article-title":"Synergy between next generation EGFR tyrosine kinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer","volume":"108","author":"Zhao","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prp.2022.154053_bib94","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biopha.2016.11.100","article-title":"miR-200c enhances sensitivity of drug-resistant non-small cell lung cancer to gefitinib by suppression of PI3K\/Akt signaling pathway and inhibites cell migration via targeting ZEB1","volume":"85","author":"Zhou","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"31","key":"10.1016\/j.prp.2022.154053_bib95","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1038\/s41388-018-0276-2","article-title":"Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin \u03b23","volume":"37","author":"Yue","year":"2018","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib96","first-page":"1331","article-title":"MicroRNA\u2011506\u20133p reverses gefitinib resistance in non\u2011small cell lung cancer by targeting Yes\u2011associated protein 1","volume":"19","author":"Zhu","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib97","first-page":"185","article-title":"The miR\u2011625\u20133p\/AXL axis induces non\u2011T790M acquired resistance to EGFR\u2011TKI via activation of the TGF\u2011\u03b2\/Smad pathway and EMT in EGFR\u2011mutant non\u2011small cell lung cancer","volume":"44","author":"Du","year":"2020","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib98","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3892\/mmr.2014.2757","article-title":"MicroRNA expression profiles associated with acquired gefitinib-resistance in human lung adenocarcinoma cells","volume":"11","author":"Ge","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.prp.2022.154053_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060317","article-title":"Gr\u00e8ve, miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.prp.2022.154053_bib100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.biopha.2013.10.007","article-title":"Fulvestrant increases gefitinib sensitivity in non-small cell lung cancer cells by upregulating let-7c expression","volume":"68","author":"Shen","year":"2014","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.prp.2022.154053_bib101","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3727\/096504018X15166204902353","article-title":"miR-135a confers resistance to gefitinib in non-small cell lung cancer cells by upregulation of RAC1","volume":"26","author":"Zhang","year":"2018","journal-title":"Oncol. Res."},{"issue":"8","key":"10.1016\/j.prp.2022.154053_bib102","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3727\/096504018X15166204902353","article-title":"miR-135a confers resistance to gefitinib in non-small cell lung cancer cells by upregulation of RAC1","volume":"26","author":"Zhang","year":"2018","journal-title":"Oncol. Res."},{"issue":"9","key":"10.1016\/j.prp.2022.154053_bib103","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/0284186X.2018.1465585","article-title":"Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab","volume":"57","author":"Halvorsen","year":"2018","journal-title":"Acta Oncol. (Stockh., Swed. )"},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib104","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.ygeno.2019.11.019","article-title":"Circulating microRNAs predict the response to anti-PD-1 therapy in non-small cell lung cancer","volume":"112","author":"Fan","year":"2020","journal-title":"Genomics"},{"key":"10.1016\/j.prp.2022.154053_bib105","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.3389\/fonc.2020.563613","article-title":"Tissue microRNA expression as a predictor of response to immunotherapy in NSCLC patients","volume":"10","author":"Grenda","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2022.154053_bib106","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/218169","article-title":"MicroRNAs-role in lung cancer","volume":"2014","author":"Guz","year":"2014","journal-title":"Dis. Markers"},{"issue":"7","key":"10.1016\/j.prp.2022.154053_bib107","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/cancers13071716","article-title":"The role of microRNAs in lung cancer metabolism","volume":"13","author":"Azizi","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.prp.2022.154053_bib108","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/cancers10060162","article-title":"p53-dependent and-independent epithelial integrity: beyond miRNAs and metabolic fluctuations","volume":"10","author":"Oikawa","year":"2018","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2022.154053_bib109","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3727\/096504017X14973124850905","article-title":"MicroRNA-138 inhibits cell growth, invasion, and EMT of non-small cell lung cancer via SOX4\/p53 feedback loop","volume":"26","author":"Li","year":"2018","journal-title":"Oncol. Res."},{"issue":"6","key":"10.1016\/j.prp.2022.154053_bib110","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/1759-7714.13457","article-title":"MicroRNA\u2010374b mediates the initiation of non\u2010small cell lung cancer by regulating ITGB1 and p53 expressions","volume":"11","author":"Zhao","year":"2020","journal-title":"Thorac. Cancer"},{"issue":"12","key":"10.1016\/j.prp.2022.154053_bib111","doi-asserted-by":"crossref","first-page":"22884","DOI":"10.1002\/jcp.28851","article-title":"p53\/miR\u201030a\u20105p\/SOX4 feedback loop mediates cellular proliferation, apoptosis, and migration of non\u2010small\u2010cell lung cancer","volume":"234","author":"Quan","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2022.154053_bib112","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.omtn.2020.11.010","article-title":"VPS33B modulates c-Myc\/p53\/miR-192-3p to target CCNB1 suppressing the growth of non-small cell lung cancer","volume":"23","author":"Liu","year":"2021","journal-title":"Mol. Ther. -Nucleic Acids"},{"issue":"6","key":"10.1016\/j.prp.2022.154053_bib113","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/onc.2013.597","article-title":"Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-\u03baB p65 to evoke reactive oxygen species generation and p53 activation","volume":"34","author":"Yin","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2022.154053_bib114","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2018.01.013","article-title":"Friend or foe: MicroRNAs in the p53 network","volume":"419","author":"Luo","year":"2018","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01169-0","article-title":"Targeting mutant p53 for cancer therapy: direct and indirect strategies","volume":"14","author":"Hu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2022.154053_bib116","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1158\/0008-5472.CAN-18-1479","article-title":"Miguel, Inhibitor of differentiation-1 sustains mutant KRAS-driven progression, maintenance, and metastasis of lung adenocarcinoma via regulation of a FOSL1 network","volume":"79","author":"Rom\u00e1n","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2022.154053_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.trecan.2022.01.002","article-title":"Interplay between K-RAS and miRNAs","author":"Shui","year":"2022","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-017-0243-9","article-title":"KRAS induces lung tumorigenesis through microRNAs modulation","volume":"9","author":"Shi","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1170-7","article-title":"Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression","volume":"38","author":"Jin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1172\/JCI82720","article-title":"MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer","volume":"126","author":"Edmonds","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.prp.2022.154053_bib121","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1159\/000485491","article-title":"MiR-193a-3p is an important tumour suppressor in lung cancer and directly targets KRAS","volume":"44","author":"Fan","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prp.2022.154053_bib122","first-page":"2210","article-title":"The clinical utility of miR-21 and let-7 in non-small cell lung Cancer (NSCLC). A systematic review and meta-analysis","author":"Pop-Bica","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2022.154053_bib123","doi-asserted-by":"crossref","unstructured":"J. Zhao, W. Hang, Q. Wang, Y. Xu, Expression and Diagnostic Efficacy of miR-126\u20135p and miR-34c-3p in Serum Extracellular Vesicles of Non-Small Cell Lung Cancer Patients, (2021).","DOI":"10.21203\/rs.3.rs-861245\/v1"},{"key":"10.1016\/j.prp.2022.154053_bib124","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijbiomac.2022.06.134","article-title":"miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapY: A spotlight on signaling pathways interplay\u2014A review","volume":"214","author":"Elrebehy","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2022.154053_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.mgene.2021.100855","article-title":"Inhibition of miR-155-5p in non-small cell lung cancer, a potential target for induction of autophagy","volume":"28","author":"Moayedi","year":"2021","journal-title":"Meta Gene"},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3892\/ijo.2017.3999","article-title":"MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN\/PI3K\/AKT signaling pathway in non-small cell lung cancer metastasis","volume":"51","author":"Lu","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"30","key":"10.1016\/j.prp.2022.154053_bib127","doi-asserted-by":"crossref","first-page":"30239","DOI":"10.18632\/oncotarget.4972","article-title":"MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-020-01261-0","article-title":"miRNA-425-5p enhances lung cancer growth via the PTEN\/PI3K\/AKT signaling axis","volume":"20","author":"Zhou","year":"2020","journal-title":"BMC Pulm. Med."},{"issue":"7","key":"10.1016\/j.prp.2022.154053_bib129","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1002\/cam4.2220","article-title":"MicroRNA\u20104286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K\/Akt pathway in non\u2010small cell lung cancer","volume":"8","author":"Ling","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2022.154053_bib130","article-title":"MicroRNA-103a-3p promotes cell proliferation and invasion in non-small-cell lung cancer cells through akt pathway by targeting PTEN","volume":"2021","author":"Li","year":"2021","journal-title":"BioMed. Res. Int."},{"issue":"3","key":"10.1016\/j.prp.2022.154053_bib131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2217\/epi-2021-0229","article-title":"MiR-421 promotes lipid metabolism by targeting PTEN via activating PI3K\/AKT\/mTOR pathway in non-small cell lung cancer","volume":"14","author":"Xu","year":"2022","journal-title":"Epigenomics"},{"key":"10.1016\/j.prp.2022.154053_bib132","article-title":"Negative Regulation of PTEN by microRNA-221 and its association with drug resistance and cellular senescence in lung cancer cells","volume":"2018","author":"Wang","year":"2018","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.prp.2022.154053_bib133","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/OTT.S225010","article-title":"miR-1269b drives cisplatin resistance of human non-small cell lung cancer via modulating the PTEN\/PI3K\/AKT signaling pathway","volume":"13","author":"Yang","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib134","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3892\/ol.2016.5423","article-title":"MicroRNA\u2011101 suppresses progression of lung cancer through the PTEN\/AKT signaling pathway by targeting DNA methyltransferase 3A","volume":"13","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3727\/096504019X15732109856009","article-title":"MicroRNA-561 affects proliferation and cell cycle transition through PTEN\/AKT signaling pathway by targeting P-REX2a in NSCLC","volume":"28","author":"Liao","year":"2020","journal-title":"Oncol. Res."},{"issue":"4","key":"10.1016\/j.prp.2022.154053_bib136","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1007\/s11033-021-06379-w","article-title":"Application of the conventional and novel methods in testing EGFR variants for NSCLC patients in the last 10 years through different regions: a systematic review","volume":"48","author":"Obradovic","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.prp.2022.154053_bib137","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/carcin\/bgy044","article-title":"Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR","volume":"39","author":"Torigoe","year":"2018","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000434741","article-title":"MicroRNA-200a targets EGFR and c-Met to inhibit migration, invasion, and gefitinib resistance in non-small cell lung cancer","volume":"146","author":"Zhen","year":"2015","journal-title":"Cytogenet. Genome Res."},{"issue":"12","key":"10.1016\/j.prp.2022.154053_bib139","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.ejca.2009.04.039","article-title":"Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation","volume":"45","author":"Cho","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.prp.2022.154053_bib140","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/jcmm.12889","article-title":"miR\u2010134 inhibits non\u2010small cell lung cancer growth by targeting the epidermal growth factor receptor","volume":"20","author":"Qin","year":"2016","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.prp.2022.154053_bib141","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3892\/etm.2016.3555","article-title":"miR-143 suppresses the proliferation of NSCLC cells by inhibiting the epidermal growth factor receptor","volume":"12","author":"Zhang","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.prp.2022.154053_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2021.12718","article-title":"MicroRNA\u2011133a\u20113p suppresses malignant behavior of non\u2011small cell lung cancer cells by negatively regulating ERBB2","volume":"21","author":"Xu","year":"2021","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib143","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11033-021-06844-6","article-title":"The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway","volume":"49","author":"Hashemi","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.prp.2022.154053_bib144","article-title":"The role of miRNA-571 and miRNA-559 in lung cancer by affecting the expression of genes associated with the ErbB signaling pathway","volume":"26","author":"Jasim","year":"2022","journal-title":"Gene Rep."},{"issue":"22","key":"10.1016\/j.prp.2022.154053_bib145","doi-asserted-by":"crossref","first-page":"12496","DOI":"10.3390\/ijms222212496","article-title":"CelL behavior of non-small cell lung cancer Is At EGFR and MicroRNAs hands","volume":"22","author":"Hassanein","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2022.154053_bib146","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919850665","article-title":"The p53\/miR-193a\/EGFR feedback loop function as a driving force for non-small cell lung carcinoma tumorigenesis","volume":"11","author":"Wang","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2022.154053_bib147","first-page":"4803","article-title":"MicroRNA\u2011128\u2013b regulates epidermal growth factor receptor expression in non\u2011small cell lung cancer","volume":"20","author":"Li","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.prp.2022.154053_bib148","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.50","article-title":"MicroRNA-34a\/EGFR axis plays pivotal roles in lung tumorigenesis","volume":"6","author":"Li","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.prp.2022.154053_bib149","article-title":"Wnt\/\u03b2-catenin signaling pathway in lung cancer","author":"Zhu","year":"2021","journal-title":"Med. Drug Discov."},{"key":"10.1016\/j.prp.2022.154053_bib150","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/DMSO.S187422","article-title":"Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients","volume":"12","author":"Zaki","year":"2019","journal-title":"Diabetes, Metab. Syndr. Obes. Targets Ther."},{"key":"10.1016\/j.prp.2022.154053_bib151","series-title":"Circulating miR-148a-5p and miR-21-5p as Novel Diagnostic Biomarkers in Adult Egyptian Male Patients with Metabolic Syndrome","author":"Doghish","year":"2021"},{"issue":"18","key":"10.1016\/j.prp.2022.154053_bib152","first-page":"2515","article-title":"miR-199a regulates the biological activity of non-small cell lung cancer cells via Wnt3a\/\u03b2-catenin signaling pathway","volume":"36","author":"Zhang","year":"2020","journal-title":"J. Pr. Med."},{"key":"10.1016\/j.prp.2022.154053_bib153","first-page":"871","article-title":"Inhibition of proliferation invasion and migration mechanism of lung cancer cells by miRNA-543","volume":"27","author":"Li","year":"2020","journal-title":"Chin. J. Cancer Prev. Treat."},{"issue":"3","key":"10.1016\/j.prp.2022.154053_bib154","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/1440-1681.13203","article-title":"MicroRNA-147b suppresses the proliferation and invasion of non-small-cell lung cancer cells through downregulation of Wnt\/\u03b2-catenin signalling via targeting of RPS15A","volume":"47","author":"Ning","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib155","article-title":"MiR-191-5p inhibits lung adenocarcinoma by repressing SATB1 to inhibit Wnt pathway, Molecular Genetics & Genomic","volume":"8","author":"Zhou","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.prp.2022.154053_bib156","first-page":"1","article-title":"MiR-590 suppresses the progression of non-small cell lung cancer by regulating YAP1 and Wnt\/\u03b2-catenin signaling","author":"Hao","year":"2022","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib157","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12935-021-02197-z","article-title":"MicroRNA-550a-3-5p controls the brain metastasis of lung cancer by directly targeting YAP1","volume":"21","author":"Wei","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.prp.2022.154053_bib158","first-page":"2931","article-title":"MicroRNA-545 targets ZEB2 to inhibit the development of non\u2011small cell lung cancer by inactivating Wnt\/\u03b2-catenin pathway","volume":"18","author":"Cui","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2022.154053_bib159","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9652420","article-title":"MicroRNA-520a suppresses pathogenesis and progression of non-small-cell lung cancer through targeting the RRM2\/Wnt axis","volume":"2021","author":"Xie","year":"2021","journal-title":"Anal. Cell. Pathol."},{"key":"10.1016\/j.prp.2022.154053_bib160","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.omtn.2019.04.017","article-title":"miR-150-5p inhibits non-small-cell lung cancer metastasis and recurrence by targeting HMGA2 and \u03b2-catenin signaling","volume":"16","author":"Dai","year":"2019","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.prp.2022.154053_bib161","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7782963","article-title":"Nobiletin inhibits non-small-cell lung cancer by inactivating WNT\/\u03b2-catenin signaling through downregulating miR-15-5p","volume":"2021","author":"Han","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.prp.2022.154053_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111111","article-title":"Progress of exosomes in the diagnosis and treatment of lung cancer","volume":"134","author":"Xu","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.prp.2022.154053_bib163","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/iub.2430","article-title":"Long non\u2010coding RNAs as potential biomarkers in the prognosis and diagnosis of lung cancer: a review and target analysis","volume":"73","author":"Aftabi","year":"2021","journal-title":"IUBMB life"},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib164","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3816\/CLC.2009.n.006","article-title":"Exosomal microRNA: a diagnostic marker for lung cancer","volume":"10","author":"Rabinowits","year":"2009","journal-title":"Clin. lung Cancer"},{"issue":"10","key":"10.1016\/j.prp.2022.154053_bib165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078649","article-title":"Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma","volume":"8","author":"Aushev","year":"2013","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.prp.2022.154053_bib166","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/JTO.0b013e318299ac32","article-title":"microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer","volume":"8","author":"Cazzoli","year":"2013","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2022.154053_bib167","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.18632\/oncotarget.14311","article-title":"A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.prp.2022.154053_bib168","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/jcmm.13056","article-title":"Circulating exosomal microRNA\u201096 promotes cell proliferation, migration and drug resistance by targeting LMO7","volume":"21","author":"Wu","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-15475-6","article-title":"Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression","volume":"7","author":"Grimolizzi","year":"2017","journal-title":"Sci. Rep."},{"issue":"34","key":"10.1016\/j.prp.2022.154053_bib170","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1038\/onc.2017.105","article-title":"Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1","volume":"36","author":"Hsu","year":"2017","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.prp.2022.154053_bib171","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S1556-0864(16)30184-8","article-title":"71P Exosomes isolated in plasma of non-small cell lung cancer patients contain microRNA related to the EGFR pathway: proof of concept","volume":"11","author":"Rolfo","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"17","key":"10.1016\/j.prp.2022.154053_bib172","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1158\/1078-0432.CCR-17-0577","article-title":"Evaluation of tumor-derived exosomal miRNA as potential diagnostic biomarkers for early-stage non\u2013small cell lung cancer using next-generation sequencing","volume":"23","author":"Jin","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.prp.2022.154053_bib173","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/gcc.22181","article-title":"Different exosome cargo from plasma\/bronchoalveolar lavage in non\u2010small\u2010cell lung cancer, Genes","volume":"53","author":"Rodr\u00edguez","year":"2014","journal-title":"Chromosomes Cancer"},{"issue":"44","key":"10.1016\/j.prp.2022.154053_bib174","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008361","article-title":"Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.prp.2022.154053_bib175","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.1007\/s13277-015-4779-y","article-title":"CASP 3 genetic polymorphisms and risk of Hepatocellular carcinoma: a case-control study in a Chinese population","volume":"37","author":"Deng","year":"2016","journal-title":"Tumor Biol."},{"issue":"7","key":"10.1016\/j.prp.2022.154053_bib176","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/cancers10070224","article-title":"Current molecular-targeted therapies in NSCLC and their mechanism of resistance","volume":"10","author":"Schrank","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2022.154053_bib177","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.e23035","article-title":"Follow up analysis by exosomal miRNAs in EGFR mutated non-small cell lung cancer (NSCLC) patients during osimertinib (AZD9291) treatment: A potential prognostic biomarker tool","author":"Giallombardo","year":"2016","journal-title":"Am. Soc. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-016-0636-4","article-title":"Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer","volume":"11","author":"Dinh","year":"2016","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib179","first-page":"1","article-title":"Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells","volume":"35","author":"Tang","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.prp.2022.154053_bib180","first-page":"2650","article-title":"MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer","volume":"21","author":"Yuwen","year":"2017","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0694-8","article-title":"Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p","volume":"16","author":"Wei","year":"2017","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2022.154053_bib182","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/cam4.2031","article-title":"Comprehensive clinical profiling of the Gauting locoregional lung adenocarcinoma donors","volume":"8","author":"Klotz","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2022.154053_bib183","first-page":"27","article-title":"Exosomes in lung cancer diagnosis and treatment","volume":"151","author":"Masaoutis","year":"2018","journal-title":"Transl. Res. Future Clin. Pract., Biochim."},{"key":"10.1016\/j.prp.2022.154053_bib184","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.canlet.2018.02.002","article-title":"Exosomal microRNAs (exomiRs): Small molecules with a big role in cancer","volume":"420","author":"Bhome","year":"2018","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.prp.2022.154053_bib185","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3892\/ol.2017.5569","article-title":"Exosomal microRNA in plasma as a non\u2011invasive biomarker for the recurrence of non\u2011small cell lung cancer","volume":"13","author":"Dejima","year":"2017","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.prp.2022.154053_bib186","doi-asserted-by":"crossref","first-page":"13048","DOI":"10.18632\/oncotarget.14369","article-title":"Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-018-0949-y","article-title":"Downregulation of exosomal let-7a-5p in dust exposed-workers contributes to lung cancer development","volume":"19","author":"Zhang","year":"2018","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.prp.2022.154053_bib188","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.drudis.2021.02.023","article-title":"Point-of-care diagnostics approaches for detection of lung cancer-associated circulating miRNAs","volume":"26","author":"Shandilya","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib189","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jhg.2016.87","article-title":"MicroRNAs in extracellular vesicles: potential cancer biomarkers","volume":"62","author":"Kinoshita","year":"2017","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.prp.2022.154053_bib190","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.trsl.2020.11.012","article-title":"miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer","volume":"230","author":"Zhong","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.prp.2022.154053_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100844","article-title":"Integrating circulating miRNA analysis in the clinical management of lung cancer: present or future?","volume":"72","author":"Lampignano","year":"2020","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.prp.2022.154053_bib192","article-title":"Frontiers of MicroRNA signature in non-small cell lung cancer","volume":"9","author":"Zhu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.prp.2022.154053_bib193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-018-0587-8","article-title":"The role and mechanisms of action of microRNAs in cancer drug resistance","volume":"11","author":"Si","year":"2019","journal-title":"Clin. Epigen."},{"key":"10.1016\/j.prp.2022.154053_bib194","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.3389\/fimmu.2018.02491","article-title":"MicroRNAs: pleiotropic regulators in the tumor microenvironment","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.prp.2022.154053_bib195","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/cancers13071526","article-title":"microRNAs as novel therapeutics in cancer","volume":"13","author":"Romano","year":"2021","journal-title":"Cancers"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:54:26Z","timestamp":1759733666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822002977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":195,"alternative-id":["S0344033822002977"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.154053","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.154053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154053"}}